Xtant Medical Holdings Reports Key Events
Ticker: XTNT · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1453593
| Field | Detail |
|---|---|
| Company | Xtant Medical Holdings, Inc. (XTNT) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-condition, change-of-control
TL;DR
Xtant Medical Holdings filed an 8-K detailing material agreements, financials, and control changes as of April 15, 2025.
AI Summary
Xtant Medical Holdings, Inc. filed an 8-K on April 16, 2025, reporting several key events as of April 15, 2025. These include the termination of a material definitive agreement, results of operations and financial condition, changes in control of the registrant, and Regulation FD disclosures. The filing also covers other events and financial statements/exhibits.
Why It Matters
This 8-K filing signals significant corporate actions and financial updates for Xtant Medical Holdings, Inc., which could impact its stock performance and investor outlook.
Risk Assessment
Risk Level: medium — The filing indicates significant corporate events including termination of agreements and potential changes in control, which can introduce uncertainty.
Key Players & Entities
- Xtant Medical Holdings, Inc. (company) — Registrant
- April 15, 2025 (date) — Date of earliest event reported
- April 16, 2025 (date) — Filing date
FAQ
What specific material definitive agreement was terminated by Xtant Medical Holdings, Inc.?
The filing indicates the termination of a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What are the key updates regarding Xtant Medical Holdings, Inc.'s results of operations and financial condition?
The filing states that results of operations and financial condition are being reported, but the specific financial details are not included in the provided text.
Are there any changes in control of Xtant Medical Holdings, Inc. reported in this filing?
Yes, the filing explicitly lists 'Changes in Control of Registrant' as an item of disclosure.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD Disclosure indicates that the company is making public disclosures to prevent selective disclosure of material non-public information.
What former company names has Xtant Medical Holdings, Inc. previously operated under?
Xtant Medical Holdings, Inc. was formerly known as Bacterin International Holdings, Inc. (name change on 20100615) and K KITZ INC (name change on 20090108).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Xtant Medical Holdings, Inc. (XTNT).